ME 23andMe Inc.: Quarterly Revenue Growth

Symbol and logo of brand 23andMe Inc. (ME)

Risks for 23andMe Holding Co. (ME) are linked to discretionary demand for DNA tests and vulnerability to crises. On the GURU.Markets platform, the percentage growth of quarterly revenue visualizes these fluctuations, where the 34.40 mark indicates the current state. Stability is provided by its status as a pioneer of personalized genetics with the largest database, as well as its independence from macroeconomics due to the demand for innovative medical developments.

23andMe Holding Co (ME) - Quarterly Revenue Increase from 07/04/2022 to 04/05/2025

Analytical breakdowns and data insights for company 23andMe Holding Co (ME)

- current quotes and average value forecast:
- cash and cash flow data:
Fundamental company valuation:23andMe (ME)
Mass-produced product of 23andMe

23andMe Holding Co. (ME) leverages diversification through the synthesis of consumer genetic testing and pharmaceutical development, allowing the company to monetize a unique DNA dataset for drug discovery. By analyzing the quarterly revenue history on GURU.Markets, an investor can assess the percentage growth in sales relative to the same period last year, which confirms a recovery in demand and determines capital stability without the risk of overpaying for success already priced in.

Direct competitors

A - Revenue Growth QoQ|Quarterly Sales Growth Rate Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Quarterly Sales Growth|Quarterly Sales Growth Cologuard|RVTY (Revvity Corp) - Quarterly Revenue Growth|Quarterly Revenue Growth Bio-Rad Laboratories Inc|Quarterly Sales Growth NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Quarterly Revenue Increase|Revenue Growth QoQ QuidelOrtho Inc. QDEL|Quarterly Revenue Growth OPKO Health Inc OPK|CareDx Inc - Quarterly Revenue Growth|Quarterly Revenue Increase MRVI (Maravai)|FLGT: Quarterly Revenue Growth|LAB (Standard BioTools Inc.) - Revenue Growth QoQ|Revenue Growth QoQ Cytek Biosciences Inc|Quarterly Revenue Growth Rate OraSure OSUR|Quarterly Sales Growth XGN (Exagen Diagnostics)|Quarterly Sales Growth Rate MDxHealth Inc.|Revenue Growth QoQ Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Quarterly Revenue Growth Rate|Insight Molecular Diagnostics Inc - Quarterly Revenue Growth|Quarterly Revenue Growth Rate trinitybiotech.com|PRPH (ProPhase) - Quarterly Sales Growth|Sales Growth QoQ AIMD|Quarterly Sales Growth CODX|Quarterly Revenue Growth Rate heartsciences.com HSCS|Revenue Growth QoQ Biomerica Inc. (BMRA)|Quarterly Sales Growth Rate Cardio Diagnostics Holdings|Quarterly Revenue Growth ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Quarterly Revenue Growth Rate|bluejaydx.com - Quarterly Revenue Growth|Aspira Women's Health - Sales Change QoQ|AXDX (Accelerate Diagnostics) - Quarterly Sales Growth|Quarterly Sales Growth CENTOGENE, N.V.|Revenue Growth QoQ enzo.com|Quarterly Revenue Growth Fresh2 Group Limited|Quarterly Revenue Growth GENE|Revenue Growth QoQ PMD (Psychemedics Corporation)